<img height="1" width="1" style="display:none" src="https://flask.nextdoor.com/pixel?pid=cd602bda-7a11-4dbd-9bd1-0a68da1d2a8a&amp;ev=PAGE_VIEW&amp;noscript=1">
TSS_alternate_logo_v1b (long)-1
BBB_ABSeal_H_7469_US-1201x428-6fc592e
BBB Pinnacle Award Winner for 2014, 2016, 2017, and 2025
BBB Winner of Distinction since 2011 

1-855-952-1941 TTY: 711
Monday - Friday 8am-8pm Central Standard Time
Saturday: By Appointment

A Robot Taking Your Blood? Meet the FDA-Authorized Aletta

08/20/26 | 11:20 AM | 5 Min Read
A Robot Taking Your Blood? Meet the FDA-Authorized Aletta

The Future of Phlebotomy is Here

On August 19, 2026, the medical world took a massive leap forward. The FDA officially granted De Novo authorization to Aletta, a groundbreaking medical innovation developed by Vitestro. For the first time, a standalone robotic device is legally authorized to draw blood from an adult patient's arm autonomously, without any hands-on intervention from a human operator. Designed specifically for outpatient settings, this clearance creates an entirely new regulatory category for robotic phlebotomy.

How the Aletta Device Works

While the idea of a robot drawing your blood might sound like science fiction, Aletta is designed to be gentle, precise, and completely independent.

  • Smart Imaging: The device uses a combination of near-infrared light and Doppler ultrasound to locate the perfect vein, regardless of skin tone or body type.
  • Complete Automation: Aletta handles every step, from applying the tourniquet and cleaning the skin to inserting the needle with submillimeter precision,.
  • Post-Draw Care: Once the sample is collected, it safely removes the needle, changes the collection tubes, and applies the bandage.
  • Built-in Safety: Advanced sensors constantly monitor the patient and will instantly halt the procedure if unexpected movement is detected.

Solving the Healthcare Staffing Crisis

Beyond the incredible technology, Aletta was built to solve a very real, human problem: the nationwide phlebotomist shortage. Because the robot handles the physical blood draw, a single trained phlebotomy supervisor can simultaneously oversee up to three Aletta devices at once. This drastically increases clinic efficiency and reduces wait times.

A Better Patient Experience

Getting blood drawn is rarely an enjoyable task, but Aletta’s consistency aims to change that. By removing the variability of human error, the device promises a highly predictable, standardized experience that may finally put needle-phobic patients at ease.

Feature Traditional Blood Draw Aletta Robotic Draw
Operator Hands-on Phlebotomist Autonomous Device
Vein Detection Visual and Tactile Near-Infrared & Ultrasound
Oversight 1:1 (Staff to Patient) 1:3 (Staff to Devices)

 

 

 

Sources:

  • WKYC: FDA approves first-of-its-kind robotic device
  • Clinical Lab Products (CLP): FDA Authorizes First Standalone Robotic Blood Draw Device
  • Fox 9 News / FDA: Robotic blood draw device authorizations
  • Citeline / Medtech Insight: FDA De Novo For Aletta Creates New Regulatory Category
  • Vitestro Official Data: Aletta Autonomous Robotic Phlebotomy Device capabilities

Recent Posts